New shingles drug could beat current standard for pain relief

NCT ID NCT07099157

Recruiting now Symptom relief Sponsor: Peking University Third Hospital Source: ClinicalTrials.gov ↗

First seen Jan 05, 2026 · Last updated May 14, 2026 · Updated 25 times

Summary

This study compares two antiviral drugs, brivudine and famciclovir, to see which is better at reducing pain from shingles and preventing long-term nerve pain. About 140 adults with shingles will take one of the two medicines. Researchers will track pain levels over 90 days and check how quickly skin sores heal.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
RECRUITING

Beijing, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Peking University First Hospital
RECRUITING

Beijing, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Peking University Third Hospital
RECRUITING

Beijing, 100191, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Xuanwu Hospital, Capital Medical University
NOT_YET_RECRUITING

Beijing, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HERPES ZOSTER